WebApr 10, 2024 · Common Stock, par value $0.00001: PTGX: The Nasdaq Stock Market, LLC: ... (the "Common Stock"). The price to the public in this offering is $20.00 per share, and the Underwriters have agreed to purchase the shares from the Company pursuant to the Underwriting Agreement at a price of $18.80 per share. ... All news about PROTAGONIST … Web1 day ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Protagonist Therapeutics (PTGX)
Protagonist Therapeutics, Inc. (PTGX) Latest Stock News
WebMar 18, 2024 · Get Protagonist Therapeutics Inc (PTGX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebApr 13, 2024 · Dupont Capital Management Corp purchased a new stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Get Rating) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 13,127 shares of the company's stock, valued at approximately $143,000. A pprosemary套图
Current Report Filing (8-k)
WebMar 18, 2024 · (NASDAQ: PTGX) Protagonist Therapeutics stock price per share is $22.42 today (as of Mar 17, 2024). ... Protagonist Therapeutics 's market cap is calculated by … WebApr 13, 2024 · 4 Wall Street research analysts have issued twelve-month target prices for Protagonist Therapeutics' stock. Their PTGX share price forecasts range from $28.00 to … WebFind real-time PTGX - Protagonist Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. pprom signs and symptoms